Source comparison
Two distinct biological theories of ageing: telomere attrition versus immune senescence
Epitalon (Ala-Glu-Asp-Gly, ~390.3Da) and Thymosin Alpha-1 (Tα1, 28 amino acids, ~3108Da) represent mechanistically distinct research approaches to the biology of organismal ageing, addressing two of the most extensively characterised “hallmarks of ageing” — te
This comparison does not assign a generated winner or score.
- Epitalon (Ala-Glu-Asp-Gly, ~390.3Da) and Thymosin Alpha-1 (Tα1, 28 amino acids, ~3108Da) represent mechanistically distinct research approaches to the biology of organismal ageing, addressing two of the most extensively characterised “hallmarks of ageing” — telomere attrition and immune senescence — that are theorised to drive the multisystem functional decline characteristic of biological ageing.
- The telomere attrition theory holds that progressive telomere shortening in somatic cell populations — due to the end-replication problem of DNA polymerase — acts as a cellular mitotic counter that triggers replicative senescence and apoptosis as proliferative tissues exhaust their telomere reserve. In rapidly dividing populations (haematopoietic stem cells, intestinal crypts, satellite cells, hepatocytes), telomere shortening is the primary determinant of regenerative capacity exhaustion with age. Epitalon’s TERT (telomerase reverse transcriptase) activation addresses this mechanism directly.
- The immune senescence theory holds that the progressive loss of thymic output — quantified by declining sjTREC (signal joint T-cell receptor excision circles) — impairs the naive T-cell diversity and regulatory T-cell pool required for effective immune surveillance, resulting in both increased infection susceptibility and increased cancer risk and autoimmune-like chronic inflammation (inflammaging) that drives multisystem ageing pathology. Thymosin Alpha-1’s thymic support and T-cell maturation mechanisms address this axis directly.
- These are not competing theories but complementary mechanisms operating at different biological levels — one at the chromosomal/cellular senescence level, one at the immune regulatory/thymic level. A rigorous research programme in longevity biology should address both axes and characterise their relative contributions to ageing phenotypes in a given model system.
- 🔗 Related Reading: For comprehensive coverage of Epitalon research, telomere biology, and longevity mechanisms, see our Epitalon Pillar Guide.